Cleared Traditional

K222706 - iCE-SG2 Subcutaneous Electrode Kit (FDA 510(k) Clearance)

Dec 2022
Decision
90d
Days
Class 2
Risk

K222706 is an FDA 510(k) clearance for the iCE-SG2 Subcutaneous Electrode Kit. This device is classified as a Electrode, Depth (Class II - Special Controls, product code GZL).

Submitted by Ice Neurosystems, Inc. (Washington, US). The FDA issued a Cleared decision on December 6, 2022, 90 days after receiving the submission on September 7, 2022.

This device falls under the Neurology FDA review panel. Regulated under 21 CFR 882.1330.

Submission Details

510(k) Number K222706 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 07, 2022
Decision Date December 06, 2022
Days to Decision 90 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary Summary PDF

Device Classification

Product Code GZL - Electrode, Depth
Device Class Class II - Special Controls
CFR Regulation 21 CFR 882.1330